The Efficacy of a Mindfulness-Based Virtual Reality Intervention to Reduce Pain in Postoperative Patients
VR-MindPain
Assessing the Effectiveness of a Mindfulness-Based Virtual Reality Intervention to Reduce Pain in Postoperative Patients: A Controlled Clinical Study
1 other identifier
interventional
64
0 countries
N/A
Brief Summary
The goal of this randomized clinical trial is to evaluate whether a virtual reality (VR) mindfulness intervention can reduce anxiety and postoperative pain in adults undergoing surgery, primarily hernia and varicose vein procedures. The main research questions are:
- Does a preoperative VR mindfulness intervention reduce anxiety before surgery?
- Does this reduction in anxiety result in lower postoperative pain compared to usual care?
- Does the intervention help prevent chronic pain two weeks after surgery? Researchers will compare a VR mindfulness intervention group with a treatment-as-usual (TAU) group to assess the intervention's effectiveness. Participants will:
- Be randomly assigned to one of two groups:
- Experimental group: Receive a VR mindfulness session on the first day of hospitalization (one day before surgery).
- Control group: Receive standard hospital care (no intervention).
- Complete psychological and pain assessments at four time points:
- Before the intervention (Day 1)
- Immediately after the intervention (only the experimental group, Day 1)
- After surgery (Day 2)
- Two weeks after surgery (follow-up)
- Report pain intensity using the Numeric Rating Scale (NRS) at four postoperative time points. Before enrollment, participants will undergo a structured interview to assess eligibility. This study aims to determine whether reducing preoperative anxiety through VR mindfulness contributes to improved pain management and a lower risk of developing chronic pain following surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2025
CompletedFirst Posted
Study publicly available on registry
May 8, 2025
CompletedStudy Start
First participant enrolled
May 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 5, 2025
CompletedMay 8, 2025
May 1, 2025
2 months
April 16, 2025
May 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Pain Intensity Measured by Brief Pain Inventory (BPI) .
This tool assesses both pain intensity and its impact on daily functioning (e.g., sleep, work, social interactions). The BPI consists of 9 items, each rated on a 0-10 scale, where 0 indicates no pain or interference and 10 represents the worst possible pain or interference.
The BPI will be administered at three time points: preoperatively (Day 1 of hospitalization), postoperatively (Day 2, the day of surgery), and at follow-up (2 weeks after surgery).
Change in Pain Intensity Measured by Numeric Rating Scale (NRS)
Participants will rate their pain intensity on a 0-10 scale, where 0 indicates no pain and 10 represents the worst imaginable pain. NRS assessments will be conducted at four postoperative time points. This approach helps minimize the influence of analgesics and anesthetics on reported pain levels. By spreading out the measurements, we reduce the risk that a single time point reflects only the temporary effects of medication, thus allowing for more reliable and valid comparisons between treatment groups.
The NRS will be administered four times throughout the day following the surgery.
Secondary Outcomes (3)
Change in Anxiety Levels Measured by State-Trait Anxiety Inventory - State version (STAI-S)
STAI-S measures will be administered: Preoperative/Pre-intervention (Day 1 of hospitalization) Post-intervention (Day 1, within 15 minutes after the VR session), Postoperative (Day 2, day of surgery), Follow-up (2 weeks after surgery).
Change in Anxiety Levels Measured by State-Trait Anxiety Inventory - Trait version (STAI-T)
STAI-T will be administered preoperatively, on Day 1 of hospitalization.
Change in Anxiety Levels Measured by Hospital Anxiety and Depression Scale (HADS).
Preoperative/Pre-intervention (Day 1 of hospitalization) Postoperative (Day 2, day of surgery) Follow-up (2 weeks after surgery)
Other Outcomes (8)
Change in Quality of Life Measured by EUROHIS-QOL.
Preoperative/Pre-intervention (Day 1 of hospitalization), Postoperative (Day 2, day of surgery), and Follow-up (2 weeks after surgery)
Change in Sleep Quality Measured by Pittsburgh Sleep Quality Index (PSQI)
Preoperative/Pre-intervention (Day 1 of hospitalization), Postoperative (Day 2, day of surgery), and Follow-up (2 weeks after surgery)
Change in Emotional Balance Measured by the Equanimity Scale-16 (ES-16)
Preoperative/Pre-intervention (Day 1 of hospitalization), Postoperative (Day 2, day of surgery), and Follow-up (2 weeks after surgery)
- +5 more other outcomes
Study Arms (2)
VR Mindfulness Intervention Group
EXPERIMENTALParticipants in this arm will undergo a structured protocol including a VR-based mindfulness intervention. Patients are guided through psychoeducation about mindfulness, and the VR procedure. Patients are invited to express their worries about the intervention or the surgery, which are normalized and addressed through reflective listening. The mindfulness session in VR lasts approximately 10 minutes and is supervised by the clinical psychologist. A structured debriefing follows the VR session, using the 4Fs model: Feelings: How did the patient feel during the session? Findings: Did they discover anything helpful or meaningful? Futures: How can they apply mindfulness during hospitalization or at home? Follow-up: They receive a home practice suggestion (4x4 breathing technique) connected to a meaningful thought, image, or feeling from the VR session. Assesments at four time points.
Treatment as Usual (TAU) Group
NO INTERVENTIONParticipants in this group will receive the standard preoperative and postoperative care provided by the hospital, without any additional intervention from the research team. Assesments at 3 time points. 1. Before the intervention (Day 1) 2. After surgery (Day 2) 3. Two weeks after surgery (follow-up)
Interventions
VR Mindfulness-Based Relaxation is a behavioral intervention that utilizes a VR application designed to reduce anxiety and promote relaxation. Participants in the experimental group will undergo a single VR session, scheduled on the day of hospital admission (one day prior to surgery). The session lasts approximately 10 minutes and features an immersive beach environment combined with an audio-guided mindfulness exercise focused on breath awareness. Following the session, participants will engage in a brief, structured debriefing, during which they will reflect on what they felt, what they discovered, and how they can apply these insights during their hospital stay. Participants will also be instructed to practice the 4-1-4 breathing technique three times per day during hospitalization. This technique involves inhaling for 4 seconds, holding the breath for 1 second, and exhaling for 4 seconds. It is intended to promote relaxation and support autonomic nervous system regulation.
Eligibility Criteria
You may qualify if:
- The participant is scheduled for surgery and is currently hospitalized for hernia or varicose vein procedures.
- The participant is on the hospital's surgical waiting list.
- The participant is willing and able to provide informed consent.
- The participant agrees to participate in the study and to complete all required assessments during hospitalization and at follow-up (either at home or during post-operative medical visits).
You may not qualify if:
- Limited proficiency in the Romanian language.
- Active substance use or alcohol use disorders that, in the opinion of the investigators, may interfere with participation.
- History of motion sickness.
- Severe visual impairment (e.g., inability to see clearly without glasses); patients who use contact lenses are not excluded.
- Use of strong opioids (e.g., morphine).
- Current suicide risk.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 16, 2025
First Posted
May 8, 2025
Study Start
May 12, 2025
Primary Completion
June 30, 2025
Study Completion
July 5, 2025
Last Updated
May 8, 2025
Record last verified: 2025-05